The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
NIHR Journals Library
2005-09-01
|
| Series: | Health Technology Assessment |
| Online Access: | https://doi.org/10.3310/hta9340 |
| _version_ | 1811231108528865280 |
|---|---|
| author | D Symmons K Tricker C Roberts L Davies P Dawes D Scott |
| author_facet | D Symmons K Tricker C Roberts L Davies P Dawes D Scott |
| author_sort | D Symmons |
| collection | DOAJ |
| first_indexed | 2024-04-12T10:39:47Z |
| format | Article |
| id | doaj.art-be430fca359f4b989b8b01cefc0601a0 |
| institution | Directory Open Access Journal |
| issn | 1366-5278 |
| language | English |
| last_indexed | 2024-04-12T10:39:47Z |
| publishDate | 2005-09-01 |
| publisher | NIHR Journals Library |
| record_format | Article |
| series | Health Technology Assessment |
| spelling | doaj.art-be430fca359f4b989b8b01cefc0601a02022-12-22T03:36:38ZengNIHR Journals LibraryHealth Technology Assessment1366-52782005-09-0193410.3310/hta9340The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritisD Symmons0K TrickerC RobertsL DaviesP DawesD ScottARC Epidemiology Unit, University of Manchester, UKhttps://doi.org/10.3310/hta9340 |
| spellingShingle | D Symmons K Tricker C Roberts L Davies P Dawes D Scott The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis Health Technology Assessment |
| title | The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis |
| title_full | The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis |
| title_fullStr | The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis |
| title_full_unstemmed | The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis |
| title_short | The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis |
| title_sort | british rheumatoid outcome study group brosg randomised controlled trial to compare the effectiveness and cost effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis |
| url | https://doi.org/10.3310/hta9340 |
| work_keys_str_mv | AT dsymmons thebritishrheumatoidoutcomestudygroupbrosgrandomisedcontrolledtrialtocomparetheeffectivenessandcosteffectivenessofaggressiveversussymptomatictherapyinestablishedrheumatoidarthritis AT ktricker thebritishrheumatoidoutcomestudygroupbrosgrandomisedcontrolledtrialtocomparetheeffectivenessandcosteffectivenessofaggressiveversussymptomatictherapyinestablishedrheumatoidarthritis AT croberts thebritishrheumatoidoutcomestudygroupbrosgrandomisedcontrolledtrialtocomparetheeffectivenessandcosteffectivenessofaggressiveversussymptomatictherapyinestablishedrheumatoidarthritis AT ldavies thebritishrheumatoidoutcomestudygroupbrosgrandomisedcontrolledtrialtocomparetheeffectivenessandcosteffectivenessofaggressiveversussymptomatictherapyinestablishedrheumatoidarthritis AT pdawes thebritishrheumatoidoutcomestudygroupbrosgrandomisedcontrolledtrialtocomparetheeffectivenessandcosteffectivenessofaggressiveversussymptomatictherapyinestablishedrheumatoidarthritis AT dscott thebritishrheumatoidoutcomestudygroupbrosgrandomisedcontrolledtrialtocomparetheeffectivenessandcosteffectivenessofaggressiveversussymptomatictherapyinestablishedrheumatoidarthritis AT dsymmons britishrheumatoidoutcomestudygroupbrosgrandomisedcontrolledtrialtocomparetheeffectivenessandcosteffectivenessofaggressiveversussymptomatictherapyinestablishedrheumatoidarthritis AT ktricker britishrheumatoidoutcomestudygroupbrosgrandomisedcontrolledtrialtocomparetheeffectivenessandcosteffectivenessofaggressiveversussymptomatictherapyinestablishedrheumatoidarthritis AT croberts britishrheumatoidoutcomestudygroupbrosgrandomisedcontrolledtrialtocomparetheeffectivenessandcosteffectivenessofaggressiveversussymptomatictherapyinestablishedrheumatoidarthritis AT ldavies britishrheumatoidoutcomestudygroupbrosgrandomisedcontrolledtrialtocomparetheeffectivenessandcosteffectivenessofaggressiveversussymptomatictherapyinestablishedrheumatoidarthritis AT pdawes britishrheumatoidoutcomestudygroupbrosgrandomisedcontrolledtrialtocomparetheeffectivenessandcosteffectivenessofaggressiveversussymptomatictherapyinestablishedrheumatoidarthritis AT dscott britishrheumatoidoutcomestudygroupbrosgrandomisedcontrolledtrialtocomparetheeffectivenessandcosteffectivenessofaggressiveversussymptomatictherapyinestablishedrheumatoidarthritis |